Jefferies Initiates Coverage On Disc Medicine with Buy Rating, Announces Price Target of $89
Portfolio Pulse from Benzinga Newsdesk
Jefferies has initiated coverage on Disc Medicine (NASDAQ:IRON) with a Buy rating and set a price target of $89, indicating a positive outlook for the company's stock.
October 23, 2024 | 10:52 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies has initiated coverage on Disc Medicine with a Buy rating and a price target of $89, suggesting a positive outlook for the stock.
The initiation of coverage by Jefferies with a Buy rating and a high price target of $89 is likely to positively influence investor sentiment and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100